相关实验视频

Updated: Sep 19, 2025

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Targeted Plasma Membrane Delivery of a Hydrophobic Cargo Encapsulated in a Liquid Crystal Nanoparticle Carrier

Published on: February 8, 2017

纳米粒子驱动的药物输送系统用于心血管治疗

Raj Patel¹, Dhruvi Patel², Unnati Dani³

¹Banas Medical College and Research Institute, Palanpur, Gujarat, India.

Journal of cardiology

|June 15, 2025

概括

心血管疾病 (CVD) 纳米医学利用纳米粒子进行向药物输送,提供安全有效的治疗方法. 这篇评论强调金属,脂质和聚合物纳米颗粒用于高血压和心肌梗塞等疾病.

科学领域:

心脏病学心脏病学
纳米医学是一种纳米医学.
生物医学工程生物医学工程

背景情况:

心血管疾病 (CVD) 是全球领先的健康问题,影响数百万,导致大量死亡.
目前的治疗方法面临着挑战,需要创新的治疗策略.
纳米材料为先进的医疗应用提供了独特的特性.

研究的目的:

审查纳米医学在治疗心血管疾病方面的临床机会和治疗潜力.
专注于用于心脏病的基于纳米粒子的药物输送系统.

主要方法:

审查基于纳米粒子治疗心血管疾病的最新进展.
度金属,脂质和聚合物纳米颗粒用于药物输送.
重点是针对性地向心脏组织输送.

主要成果:

纳米粒子对心脏组织的目标特异性和灵敏度增加.
针对心脏的纳米载体显示出治疗高血压,动脉样硬化和心肌梗塞的前景.
纳米医学为心血管疾病提供了一种安全有效的药物输送方法.

结论:

基于纳米粒子的疗法代表了心血管纳米医学的重大进步.
通过纳米颗粒传递药物具有在心血管疾病中临床应用的巨大治疗潜力.
新兴的纳米医学方法对于应对心血管疾病治疗的挑战至关重要.

关键词:

心脏组织的心脏组织.心血管疾病的心血管疾病疾病疾病疾病药物交付是药物交付的过程.纳米颗粒是指一个纳米粒子.

更多相关视频

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge

Published on: June 15, 2018

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Manufacture and Drug Delivery Applications of Silk Nanoparticles

Published on: October 8, 2016

相关概念视频

Drug Delivery: Overview

Drug Delivery: Overview

The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...